Microbix Biosystems Inc.
MBX.TO
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.19M | 14.40K | 612.20K | 322.80K | 180.30K |
| Total Depreciation and Amortization | 321.50K | 298.30K | 285.80K | 267.40K | 311.80K |
| Total Amortization of Deferred Charges | -- | -- | 24.90K | 25.50K | -- |
| Total Other Non-Cash Items | 213.10K | 192.40K | 211.60K | 188.30K | 92.10K |
| Change in Net Operating Assets | -737.70K | 168.60K | -568.20K | -242.50K | 441.50K |
| Cash from Operations | -1.39M | 673.60K | 566.30K | 561.60K | 1.03M |
| Capital Expenditure | -140.70K | -170.90K | -145.10K | -168.30K | -535.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 0.00 | -197.80K |
| Cash from Investing | -140.70K | -170.90K | -145.10K | -168.30K | -732.70K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -52.90K | -1.22M | -73.20K | -73.30K | -302.50K |
| Issuance of Common Stock | -- | 2.74M | 79.60K | 6.50K | -- |
| Repurchase of Common Stock | -266.70K | -744.30K | -511.30K | -315.00K | -162.60K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 0.00 | -- |
| Cash from Financing | -230.90K | 536.00K | -360.70K | -280.00K | -339.90K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | 0.00 | -- | -- | -- |
| Net Change in Cash | -1.76M | 1.04M | 60.50K | 113.30K | -47.00K |